QuidelOrtho
People in the News at Phase Genomics, QuidelOrtho, Inflammatix, CareDx
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 7, 2024
Craig-Hallum Upgrades QuidelOrtho to Buy
The investment bank said the company's core growth should accelerate as QuidelOrtho continues to penetrate the immunoassay market and expand its menu.
QuidelOrtho Q2 Revenues Dip 4 Percent as Firm Beats Revenue, EPS Estimates
The San Diego-based in vitro diagnostics company plans to reduce its real estate footprint by selling facilities in California and New Jersey.
QuidelOrtho Suspends Guidance After Lowering Full-Year Expectations on COVID, Savanna MDx Platform
Premium
The firm said it expects to reinstate guidance and reschedule its Investor Day at some point this year as new CEO Brian Blaser continues to assess the business.
People in the News at QuidelOrtho, Immunovia, Ultima Genomics, PreludeDx, Pixelgen, Foresight, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of April 29, 2024.
Mar 6, 2024
Mar 4, 2024
UBS Downgrades QuidelOrtho to Sell
Feb 21, 2024
QuidelOrtho Parts Ways With Longtime CEO Doug Bryant
Jan 16, 2024
Aug 9, 2023
QuidelOrtho Revenues up 8 Percent in Q2
May 4, 2023
QuidelOrtho Q1 Revenues Drop 16 Percent
Apr 13, 2023
QuidelOrtho Preliminary Q1 Revenues Beat Estimates
Feb 16, 2023